CR20140343A - Derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropina - Google Patents
Derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropinaInfo
- Publication number
- CR20140343A CR20140343A CR20140343A CR20140343A CR20140343A CR 20140343 A CR20140343 A CR 20140343A CR 20140343 A CR20140343 A CR 20140343A CR 20140343 A CR20140343 A CR 20140343A CR 20140343 A CR20140343 A CR 20140343A
- Authority
- CR
- Costa Rica
- Prior art keywords
- spiroindoline
- liberator
- gonadotropine
- antagonists
- hormone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12151291 | 2012-01-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20140343A true CR20140343A (es) | 2014-09-08 |
Family
ID=47559493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20140343A CR20140343A (es) | 2012-01-16 | 2014-07-16 | Derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropina |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20140357655A1 (es) |
| EP (1) | EP2804867A1 (es) |
| JP (1) | JP2015503607A (es) |
| KR (1) | KR20140112075A (es) |
| CN (1) | CN104169287A (es) |
| AP (1) | AP2014007738A0 (es) |
| AU (1) | AU2013211091A1 (es) |
| BR (1) | BR112014017483A8 (es) |
| CA (1) | CA2860986A1 (es) |
| CL (1) | CL2014001871A1 (es) |
| CO (1) | CO7010832A2 (es) |
| CR (1) | CR20140343A (es) |
| CU (1) | CU20140088A7 (es) |
| DO (1) | DOP2014000167A (es) |
| EA (1) | EA201491344A1 (es) |
| GT (1) | GT201400153A (es) |
| HK (1) | HK1199878A1 (es) |
| IL (1) | IL233485A0 (es) |
| MA (1) | MA35867B1 (es) |
| MX (1) | MX2014008630A (es) |
| PE (1) | PE20141699A1 (es) |
| PH (1) | PH12014501616A1 (es) |
| SG (1) | SG11201403749VA (es) |
| TN (1) | TN2014000306A1 (es) |
| WO (1) | WO2013107743A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR095785A1 (es) * | 2013-04-09 | 2015-11-11 | Bayer Pharma AG | Derivados de espiroindolina y composiciones farmacéutica de los mismos |
| WO2015007606A1 (en) * | 2013-07-15 | 2015-01-22 | Bayer Pharma Aktiengesellschaft | Spiroindoline derivatives and pharmaceutical compositions thereof |
| EP2881391A1 (en) | 2013-12-05 | 2015-06-10 | Bayer Pharma Aktiengesellschaft | Spiroindoline carbocycle derivatives and pharmaceutical compositions thereof |
| WO2015082374A1 (en) * | 2013-12-05 | 2015-06-11 | Bayer Pharma Aktiengesellschaft | Spiroindoline-thiopyran-imine-oxide derivatives as gonadotropin-releasing hormone receptor antagonists and pharmaceutical compositions thereof |
| WO2015091315A1 (en) * | 2013-12-19 | 2015-06-25 | Bayer Pharma Aktiengesellschaft | Spiro[indolin-3,4'-piperidine] derivatives as gnrh receptor antagonists |
| EP3339846B1 (en) * | 2016-12-22 | 2020-12-09 | Malvern Panalytical B.V. | Method of measuring properties of a thin film stack |
| WO2018224498A1 (en) | 2017-06-05 | 2018-12-13 | ObsEva S.A. | Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosis |
| CN107840851A (zh) * | 2017-12-21 | 2018-03-27 | 扬州大学 | 吲哚螺吡咯嗪化合物及其合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849780A (en) * | 1992-01-30 | 1998-12-15 | Sanofi | 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| TW200522944A (en) * | 2003-12-23 | 2005-07-16 | Lilly Co Eli | CB1 modulator compounds |
-
2013
- 2013-01-15 CN CN201380014647.3A patent/CN104169287A/zh active Pending
- 2013-01-15 EA EA201491344A patent/EA201491344A1/ru unknown
- 2013-01-15 US US14/371,312 patent/US20140357655A1/en not_active Abandoned
- 2013-01-15 WO PCT/EP2013/050676 patent/WO2013107743A1/en active Application Filing
- 2013-01-15 JP JP2014551648A patent/JP2015503607A/ja active Pending
- 2013-01-15 AP AP2014007738A patent/AP2014007738A0/xx unknown
- 2013-01-15 PE PE2014001114A patent/PE20141699A1/es not_active Application Discontinuation
- 2013-01-15 MX MX2014008630A patent/MX2014008630A/es unknown
- 2013-01-15 CA CA2860986A patent/CA2860986A1/en not_active Abandoned
- 2013-01-15 AU AU2013211091A patent/AU2013211091A1/en not_active Abandoned
- 2013-01-15 BR BR112014017483A patent/BR112014017483A8/pt not_active Application Discontinuation
- 2013-01-15 SG SG11201403749VA patent/SG11201403749VA/en unknown
- 2013-01-15 KR KR1020147022494A patent/KR20140112075A/ko not_active Application Discontinuation
- 2013-01-15 EP EP13700304.2A patent/EP2804867A1/en not_active Withdrawn
-
2014
- 2014-07-02 IL IL233485A patent/IL233485A0/en unknown
- 2014-07-11 PH PH12014501616A patent/PH12014501616A1/en unknown
- 2014-07-15 TN TNP2014000306A patent/TN2014000306A1/fr unknown
- 2014-07-15 CL CL2014001871A patent/CL2014001871A1/es unknown
- 2014-07-15 MA MA37214A patent/MA35867B1/fr unknown
- 2014-07-16 DO DO2014000167A patent/DOP2014000167A/es unknown
- 2014-07-16 CO CO14154059A patent/CO7010832A2/es not_active Application Discontinuation
- 2014-07-16 CR CR20140343A patent/CR20140343A/es unknown
- 2014-07-16 CU CU2014000088A patent/CU20140088A7/es unknown
- 2014-07-16 GT GT201400153A patent/GT201400153A/es unknown
-
2015
- 2015-01-13 HK HK15100323.1A patent/HK1199878A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA35867B1 (fr) | 2014-12-01 |
| CU20140088A7 (es) | 2014-12-26 |
| AP2014007738A0 (en) | 2014-07-31 |
| EA201491344A1 (ru) | 2015-04-30 |
| US20140357655A1 (en) | 2014-12-04 |
| JP2015503607A (ja) | 2015-02-02 |
| CL2014001871A1 (es) | 2014-11-03 |
| KR20140112075A (ko) | 2014-09-22 |
| SG11201403749VA (en) | 2014-07-30 |
| CA2860986A1 (en) | 2013-07-25 |
| DOP2014000167A (es) | 2014-08-31 |
| GT201400153A (es) | 2015-05-22 |
| EP2804867A1 (en) | 2014-11-26 |
| BR112014017483A2 (pt) | 2017-06-13 |
| BR112014017483A8 (pt) | 2017-07-04 |
| PE20141699A1 (es) | 2014-11-29 |
| AU2013211091A1 (en) | 2014-08-07 |
| WO2013107743A1 (en) | 2013-07-25 |
| IL233485A0 (en) | 2014-08-31 |
| PH12014501616A1 (en) | 2014-10-13 |
| HK1199878A1 (en) | 2015-07-24 |
| CO7010832A2 (es) | 2014-07-31 |
| CN104169287A (zh) | 2014-11-26 |
| MX2014008630A (es) | 2014-08-29 |
| TN2014000306A1 (en) | 2015-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20140343A (es) | Derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropina | |
| HK1252279A1 (zh) | 5- ht3受體拮抗劑 | |
| EP2964226A4 (en) | 2-pyridyloxy-4-ESTER-orexin receptor antagonists | |
| CO6920295A2 (es) | Derivados de [1,2,3]triazolo[4,5-d]pirimidina como agonistas del receptor de canabinoides 2 | |
| DK2846827T3 (da) | Biofilmdesintegration med plyss2-lysin | |
| CO6930360A2 (es) | Derivados de [1,2,3]triazolo[4,5-d]pirimidina como agonistas preferentes del receptor de canabinoides 2 | |
| CO6970595A2 (es) | Nuevos 2h-indazoles como antagonistas del receptor ep2 | |
| BR112015002950A2 (pt) | novos derivados de bicíclico-piridina | |
| SMT201500296B (it) | Antagonisti del recettore trpm8 | |
| HK1218543A1 (zh) | 新型磺酰胺 受體拮抗劑 | |
| EP2874621A4 (en) | Mineralocorticoid receptor antagonists | |
| IL244356B (en) | Formulations for cgrp receptor antagonists | |
| HK1210783A1 (en) | Octahydro-cyclopentapyrrolyl antagonists of ccr2 ccr2 | |
| CO6900142A2 (es) | Derivados de etinilo como moduladores del receptor metatrópico de glutamato | |
| HK1211588A1 (en) | Antagonists of chemokine receptors | |
| BR112015005750A2 (pt) | antagonistas peptídicos do receptor de vasopressina-2 | |
| EP2846800A4 (en) | HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS | |
| GB201213698D0 (en) | Receptor antagonists II | |
| GB201213699D0 (en) | Receptor antagonists II | |
| TH148774B (th) | อนุพันธ์ไบไซคลิค ไดไฮโดรควิโนลีน-2-โอนใหม่ | |
| UY34819A (es) | Derivados de ß-aminoácido sustituidos como antagonistas del receptor CXCR3. |